Literature DB >> 32039503

Replication-Based Rearrangements Are a Common Mechanism for SNCA Duplication in Parkinson's Disease.

Soo Hyun Seo1,2, Albino Bacolla3, Dallah Yoo4, Yoon Jung Koo2,5, Sung Im Cho2,5, Man Jin Kim2,5, Moon-Woo Seong2,5, Han-Joon Kim2,6, Jong-Min Kim2,7, John A Tainer3, Sung Sup Park2,5,8, Ji Yeon Kim8, Beomseok Jeon2,6.   

Abstract

BACKGROUND: SNCA multiplication is a genomic cause of familial PD, showing dosage-dependent toxicity. Until now, nonallelic homologous recombination was suggested as the mechanism of SNCA duplication, based on various types of repetitive elements found in the spanning region of the breakpoints. However, the sequence at the breakpoint was analyzed only for 1 case.
OBJECTIVES: We have analyzed the breakpoint sequences of 6 patients with PD who had duplicated SNCA using whole-genome sequencing data to elucidate the mechanism of SNCA duplication.
METHODS: Six patient samples with SNCA duplication underwent whole-genome sequencing. The duplicated regions were defined with nucleotide-resolution breakpoints, which were confirmed by junction polymerase chain reaction and Sanger sequencing. The search for potential non-B DNA-forming sequences and stem-loop structure predictions was conducted.
RESULTS: Duplicated regions ranged from the smallest region of 718.3 kb to the largest one of 4,162 kb. Repetitive elements were found at 8 of the 12 breakpoint sequences on each side of the junction, but none of the pairs shared overt homologies. Five of these six junctions had microhomologies (2-4 bp) at the breakpoint, and a short stretch of sequences was inserted in 3 cases. All except one junction were located within or next to stem-loop structures.
CONCLUSION: Our study has determined that homologous recombination mechanisms involving repetitive elements are not the main cause of the duplication of SNCA. The presence of microhomology at the junctions and their position within stem-loop structures suggest that replication-based rearrangements may be a common mechanism for SNCA amplification.
© 2020 International Parkinson and Movement Disorder Society. © 2020 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  zzm321990SNCA duplication; FoSTeS; MMBIR; Parkinson's disease; microhomology

Mesh:

Substances:

Year:  2020        PMID: 32039503      PMCID: PMC7359376          DOI: 10.1002/mds.27998

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  35 in total

1.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

2.  GRID2 mutations span from congenital to mild adult-onset cerebellar ataxia.

Authors:  Marie Coutelier; Lydie Burglen; Emeline Mundwiller; Myriam Abada-Bendib; Diana Rodriguez; Sandra Chantot-Bastaraud; Christelle Rougeot; Marie-Anne Cournelle; Mathieu Milh; Annick Toutain; Delphine Bacq; Vincent Meyer; Alexandra Afenjar; Jean-François Deleuze; Alexis Brice; Delphine Héron; Giovanni Stevanin; Alexandra Durr
Journal:  Neurology       Date:  2015-04-03       Impact factor: 9.910

3.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

4.  SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes.

Authors:  Eugénie Mutez; Frédéric Leprêtre; Emilie Le Rhun; Lydie Larvor; Aurélie Duflot; Vincent Mouroux; Jean-Pierre Kerckaert; Martin Figeac; Kathy Dujardin; Alain Destée; Marie-Christine Chartier-Harlin
Journal:  Hum Mutat       Date:  2011-02-08       Impact factor: 4.878

5.  Megabase Length Hypermutation Accompanies Human Structural Variation at 17p11.2.

Authors:  Christine R Beck; Claudia M B Carvalho; Zeynep C Akdemir; Fritz J Sedlazeck; Xiaofei Song; Qingchang Meng; Jianhong Hu; Harsha Doddapaneni; Zechen Chong; Edward S Chen; Philip C Thornton; Pengfei Liu; Bo Yuan; Marjorie Withers; Shalini N Jhangiani; Divya Kalra; Kimberly Walker; Adam C English; Yi Han; Ken Chen; Donna M Muzny; Grzegorz Ira; Chad A Shaw; Richard A Gibbs; P J Hastings; James R Lupski
Journal:  Cell       Date:  2019-02-28       Impact factor: 41.582

6.  A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders.

Authors:  Jennifer A Lee; Claudia M B Carvalho; James R Lupski
Journal:  Cell       Date:  2007-12-28       Impact factor: 41.582

7.  alpha-Synuclein gene duplication is present in sporadic Parkinson disease.

Authors:  T-B Ahn; S Y Kim; J Y Kim; S-S Park; D S Lee; H J Min; Y K Kim; S E Kim; J-M Kim; H-J Kim; J Cho; B S Jeon
Journal:  Neurology       Date:  2007-07-11       Impact factor: 9.910

8.  Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.

Authors:  Manuela M X Tan; Naveed Malek; Michael A Lawton; Leon Hubbard; Alan M Pittman; Theresita Joseph; Jason Hehir; Diane M A Swallow; Katherine A Grosset; Sarah L Marrinan; Nin Bajaj; Roger A Barker; David J Burn; Catherine Bresner; Thomas Foltynie; John Hardy; Nicholas Wood; Yoav Ben-Shlomo; Donald G Grosset; Nigel M Williams; Huw R Morris
Journal:  Brain       Date:  2019-09-01       Impact factor: 13.501

Review 9.  A microhomology-mediated break-induced replication model for the origin of human copy number variation.

Authors:  P J Hastings; Grzegorz Ira; James R Lupski
Journal:  PLoS Genet       Date:  2009-01-30       Impact factor: 5.917

Review 10.  Major influence of repetitive elements on disease-associated copy number variants (CNVs).

Authors:  Ana R Cardoso; Manuela Oliveira; Antonio Amorim; Luisa Azevedo
Journal:  Hum Genomics       Date:  2016-09-23       Impact factor: 4.639

View more
  7 in total

1.  Clan genomics: From OMIM phenotypic traits to genes and biology.

Authors:  James R Lupski
Journal:  Am J Med Genet A       Date:  2021-08-18       Impact factor: 2.802

2.  Robust Computational Approaches to Defining Insights on the Interface of DNA Repair with Replication and Transcription in Cancer.

Authors:  Albino Bacolla; John A Tainer
Journal:  Methods Mol Biol       Date:  2022

3.  Monitoring Nuclease Activity by X-Ray Scattering Interferometry Using Gold Nanoparticle-Conjugated DNA.

Authors:  Daniel J Rosenberg; Aleem Syed; John A Tainer; Greg L Hura
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Biology in balance: human diploid genome integrity, gene dosage, and genomic medicine.

Authors:  James R Lupski
Journal:  Trends Genet       Date:  2022-04-18       Impact factor: 11.821

5.  Distinct sequence features underlie microdeletions and gross deletions in the human genome.

Authors:  Mengling Qi; Peter D Stenson; Edward V Ball; John A Tainer; Albino Bacolla; Hildegard Kehrer-Sawatzki; David N Cooper; Huiying Zhao
Journal:  Hum Mutat       Date:  2022-02-01       Impact factor: 4.700

6.  XRCC1 promotes replication restart, nascent fork degradation and mutagenic DNA repair in BRCA2-deficient cells.

Authors:  Bradley J Eckelmann; Albino Bacolla; Haibo Wang; Zu Ye; Erika N Guerrero; Wei Jiang; Randa El-Zein; Muralidhar L Hegde; Alan E Tomkinson; John A Tainer; Sankar Mitra
Journal:  NAR Cancer       Date:  2020-08-01

7.  Integrated sequencing and array comparative genomic hybridization in familial Parkinson disease.

Authors:  Laurie A Robak; Renqian Du; Bo Yuan; Shen Gu; Isabel Alfradique-Dunham; Vismaya Kondapalli; Evelyn Hinojosa; Amanda Stillwell; Emily Young; Chaofan Zhang; Xiaofei Song; Haowei Du; Tomasz Gambin; Shalini N Jhangiani; Zeynep Coban Akdemir; Donna M Muzny; Anusha Tejomurtula; Owen A Ross; Chad Shaw; Joseph Jankovic; Weimin Bi; Jennifer E Posey; James R Lupski; Joshua M Shulman
Journal:  Neurol Genet       Date:  2020-07-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.